Skip Ribbon Commands
Skip to main content
Researchers
  • Prof.  Michael Friedman
Prof Michael Friedman
 
Research Projects   

·       Oral delivery system of GLP. 

·       Gastroretentive dosage forms.

·       Prevention and treatment of fungal infections by local application of sustained-release varnish of clotrimazole. 

·       Guided bone regeneration: stem cells and polymeric membranes.

 
 

Industry 

Consulting to local and international pharmaceutical companies.
 
 
 
Patents 
Zero-order sustained release delivery system for carbamazepine derivatives. U.S. Pat. No. 6,296,873.
 
Anti-fungal compositions with prolonged activity. U.S. Pat. No. 6,197,305.
 
Sustained release formulation of carbamazepine. U.S. Pat. No. 6,162,466.
 
Synergistic herbal extracts. U.S. Pat. No. 6,027,716.
 
Oral antifungal preventative, and method of use. U.S. Pat. No. 5,989,522.
 
Zero-order sustained release matrix tablet formulation of carbamazepine. U.S. Pat. No. 5,980,942.
 
Effervescent granules. U.S. Pat. No. 5,948,439.
 
Local oral herbal slow release tablets. U.S. Pat. No. 5,942,244.
 
Sustained-release pharmaceutical system for the delivery of antioxidants. U.S. Pat. No. 5,897,879.
 
Dental composition for hypersensitive teeth. U.S. Pat. No. 5,849,266.
 
Liquid polymer composition, and method of use. U.S. Pat. No. 5,648,399.
 
Liquid polymer composition, and method of use. U.S. Pat. No. 5,639,795.
 
Liquid polymer composition, and method of use. U.S. Pat. No.5,438,076.
 
Dental composition for hypersensitive teeth. U.S. Pat. No. 5,403,577.
 
Dental varnish composition, and method of use. U.S. Pat. No. 5,330,746.
 
Liquid polymer composition, and method of use. U.S. Pat. No. 5,160,737.
 
Dental composition for hypersensitive teeth. U.S. Pat. No. 5,139,768.
 
Oral antifungal preventative, and method of use. U.S. Pat. No. 5,116,603.
 
Sustained-release pharmaceutical compositions. U.S. Pat. No. 5,023,082.
 
Compositions for the sustained-release of chlorhexidine. U.S. Pat. No. 5,002,769.
 
Novel controlled release dosage form of valproic acid. U.S. Pat. No. 4,913,906.
 
Sustained release tablets of theophylline. U.S. Pat. No. 4,795,645.
 
website by Bynet Software Systems